From the pigments of the actinomycetes to third generation antitumor anthracyclines

Biochimie

Volumn 80, Issue 3, 1998, Pages 201-206

  Arcamone, F M ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

Analog; Anthracycline; Disaccharide

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; DOXORUBICIN DERIVATIVE; EPIRUBICIN; IDARUBICIN; PIGMENT;

ACTINOBACTERIA; ANTINEOPLASTIC ACTIVITY; BONE MARROW TOXICITY; CARDIOTOXICITY; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG STRUCTURE; REVIEW; STREPTOMYCES; STRUCTURE ACTIVITY RELATION;

EID: 0032033342     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(98)80003-5     Document Type: Article

References (44)

1. 1 Brockmann H (1963) Anthracyclinone und Anthracycline (Rhodomycinone, Pyrromycinone und Ihre Glycoside). In: Fortschritte der Chemie Organischer Naturstoffe (Zeichmeister L, ed) Springer, Vienna, 21, 121-182
2. 2 Arcamone F, Di Marco A, Gaetani M, Scotti T (1961) Isolamento ed attivit antitumorale di un antibiotico da Streptomyces sp. Giorn Microbiol 9, 83-90
3. 3 Arcamone F, Franceschi G, Orezzi P, Cassinelli G, Barbieri W, Mondelli R (1964) Daunomycin. I. The structure of daunomycinone. J Am Chem Soc 86, 5334-5335
4. 4 Arcamone F, Cassinelli G, Orezzi P, Franceschi G, Mondelli R (1964) Daunomycin. II. The structure and stereochemistry of daunosamine. J Am Chem Soc 86, 5335-5336
5. 5 Dubost M, Ganter P, Maral R, Ninet L, Preud'Homme J, Werner GH (1963) Un nouvel antibiotique a propriétes antitumorales. Compt Rend 257, 1813-1818
6. 6 Di Marco A, Gaetani M, Dorigotti L, Soldati M, Bellini O (1964) Studi sperimentali sull'attivit antineoplastica del nuovo antibiotico daunomicina. Tumori, 49, 203-217
7. 7 Arcamone F, Cassinelli G, Fantini G, Grein A, Orezzi P, Pol C, Spalla C (1969) Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S peucetius var caesius. Biotechnol Bioeng 11, 1101-1110
8. 8 Arcamone F, Cassinelli G (1984) Anthracyclines with antitumor activity. Natural Products and Drug Development (Krogsgaard-Larsen P, Brogger Christensen S, Kofod H, eds) Munksgaard, Copenhagen, 267-279
9. 9 Di Marco A, Gaetani M, Scarpinato B (1969) Adriamycin (NSC 123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep 53, 33-37
10. 10 Bonadonna G, Monfardini S, de Lena M et al (1969) Clinical evaluation of adriamycin, a new antitumor antibiotic, Br Med J 3, 503-506
11. 11 Carter SK (1975) Adriamycin, a review. J Natl Cancer Inst 55, 1265-1274
12. 12 Di Marco A, Arcamone F (1974) DNA complexing antibiotics: daunomycin, adriamycin and their derivatives. Arzneim Forsch 25, 368-375
13. 13 Arcamone F (1981) Doxorubicin, anticancer antibiotics. In: Medicinal Chemistry series (de Stevens G, ed) Academic Press, New York, 369 p
14. 14 Weiss RB, Sarosy G, Clagett-Carr K, Russo M, Leyland-Jones B (1986) Anthracycline analogs: the past, present and future. Cancer Chemother Pharmacol 18, 186-197
15. 15 Suarato A, Penco S, Vigevani A, Arcamone F (1981) Anthracycline chemistry: direct conversion of daunorubicin into the L-arabino, L-ribo, and L-lyxo analogues, and selective deoxygenation at C-4′. Carbohyd Res 98, C1-C3
16. 16 Cassinelli G, Configliacchi E, Penco S, Rivola G, Arcamone F, Pacciarini A, Ferrari L (1984) Separation, characterization, and analysis of epirubicin (4′-epidoxorubicin) and its metabolites from human urine. Drug Metab Disp 12, 506-510
17. 17 Bonadonna G (1984) Advances in Anthracycline Chemotherapy: Epirubicin. Masson, Milan, 193 p
18. 18 Arcamone F, Bernardi L, Giardino P, Patelli B, Di Marco A, Casazza AM, Pratesi G, Reggiani P (1976) Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin and their β-anomers. Cancer Treat Rep 60, 829-834
19. 19 Cabri W, De Bernardinis S, Francalanci F, Penco S (1990) A novel synthesis of (+)4-demethoxydaunomycinone. J Chem Soc Perkin Trans I, 428-429
20. 20 Cersosimo RJ (1992) Idarubicin: an anthracycline antineoplastic agent. Clin Pharmacol 11, 152-167
21. 21 Penco S, Angelucci F, Ballabio M, Barchielli G, Suarato A, Vanotti E, Vigevani A, Arcamone F (1984) Synthesis and ring A conformation of new anthracyclines. Heterocycles 21, 21-27
22. 22 Gresh N, Pullman B, Arcamone F, Menozzi M, Tonani R (1988) Joint experimental and theorethical investigation of the comparative DNA binding affinities of intercalating anthracycline derivatives. Mol Pharmacol 35, 251-256
23. 23 Wang A H-J, Ughetto G, Quigley GJ, Rich A (1987) Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complex to d(CpGpTpApCpGp) at 1.2 Å resolution. Biochemistry 26, 1152-1163
24. 24 Moore MH, Hunter WN, Langlois d'Estaintot B, Kennard O (1989) DNA-drug interactions: the crystal structure of d(CGATCG) complexed with daunomycin. J Mol Biol 206, 693
25. 25 Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F (1990) Influence of structural modifications at the 3′ and 4′ positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome drug resistance. Mol Pharmacol 45, 908-915
26. 26 Priebe W, Perez-Soler R (1993) Design and tumor targeting of anthacyclines able to overcome multidrug resistance: a double advantage approach. Pharmacol Ther 60, 215-234
27. 27 Priebe W (1995) Mechanism of action-governed design of anthracycline antibiotics: a 'turn-off/turn on approach'. Curr Drug Design 1, 73-96
28. 14C-labelled 4′-epidoxorubicin and doxorubicin in the rat: a comparative study. Cancer Chemother Pharmacol 12, 157-166
29. 14C) daunorubicin in the rat. Cancer Chemother Pharmacol 16, 107-115)
30. 30 Van Helden PD, Wiid JJF (1982) Effects of adriamycin on heart and skeletal muscle chromatin. Biochem Pharmacol 31, 973-977
31. 31 Ellis CN, Ellis MB, Blakemore WS (1987) Effect of adriamycin on heart mitochondrial DNA. Biochem J 245, 309-312
32. 32 Bellini O, Solcia E (1985) Early and late sarcoplasmic reticulum changes in doxorubicin cardiomyopathy. Virchows Arch (Cell Pathol) 49, 137-152
33. 33 Gigli M, Rasonaivo TWD, Millot J-M, Jeannesson P, Rizzo V, Jardillier J-C, Arcamone F, Manfait M (1989) Correlation between growth inhibition and intranuclear doxorubicin and 4′-deoxy-4′-iododoxorubicin quantitated in living K562 cells by microspectrofluorometry. Cancer Res 49, 560-564
34. 34 Pasqui F, Canfarini F, Giolitti A, Guidi A, Pestellini V, Arcamone F (1996) Synthesis of ring A fluorinated anthracyclines. Tetrahedron 52, 185-198
35. 35 Lombardi P, Animati F, Cipollone A, Giannini G, Monteagudo E, Arcamone F (1995) Synthesis and conformational preference of novel 8-fluoroanthracyclines. Acta Biochim Polon 42, 433-444
36. 36 Animati F, Arcamone F, Bigioni M, Capranico G, Caserini C, De Cesare M, Lombardi R, Pratesi G, Salvatore C, Supino R, Zunino F (1996) Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation. Mol Pharmacol 50, 603-609
37. 37 Boivin J, Monneret C, Païs M (1981) Approche de la synthèse d'anthracyclines oligosaccharidiques. Hémisynthèse de la 4′-O-(2-desoxy-L-fucosyl) daunorubicine. Tetrahedron 37, 4219-4228
38. 38 El Khadem HS, Matsuura D (1982) Synthesis of 7-(3-amino-2,3,6,-trideoxy-4-O-(2,6-dideoxy-α-L-lyxo-hexopyranosyl)-α-L-lyxo-hexo pyranosyl) daunomycinone. Carboydr Res 101, C1-C4
39. 39 Horton D, Priebe W, Sznaidman ML, Varela O (1993) Synthesis and antitumor activity of anthracycline disaccharide glycosides containing daunosamine. J Antibiot 46, 1720-1730
40. 40 Animati F, Berettoni M, Cipollone A, Franciotti M, Lombardi P, Monteagudo E, Arcamone F (1996) New anthracycline disaccharides. Synthesis of L-daunosaminyl-α(1-4)-2-deoxy-L-rhamnosyl and of L-daunosaminyl-α(1-4)-2-deoxy-L-fucosyl daunorubicin analogues. J Chem Soc Perkin Trans I 1327-1329
41. 41 Animati F, Arcamone F, Bigioni M, Berettoni, M, Cipollone A. Franciotti M, Lombardi P, Pratesi G, Supino R, Zunino F (1996) Novel anthracycline disaccharides: effect of the orientation of the second sugar residue on antitumor activity. Ninth NCI-OERTC Symposium on New Drugs in Cancer Therapy, Amsterdam, 12-15 March
42. 42 Pratesi G, Bigioni M, De Cesare M, Supino R, Zunino F, Animati F, Arcamone F, Berettoni M, Cipollone A, Franciotti M, Lombardi P (1996) Pharmacological properties of novel anthracycline aminodisaccharide in human lung and gynecological cancers. Preclinical studies. 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, March 12-15
43. 43 Pratesi G, Animati F, Arcamone F, Berettoni M, Bigioni M, Cipollone A, Franciotti M, Lombardi P, Supino R, Zunino F (1996) Antitumor activity of L-daunosaminyl-α-(1-4)-2-deoxy-α-L-fucosyl-4-demethoxy-adriamycinone (MEN 10755) in a panel of human tumor xeno-grafts naturally resistant to doxorubicin. Proc Am Ass Cancer Res 37, 394
44. 44 Hanauske AR (1996) Future Phase I Studies, MEN 10755. ECSG Investigators Meeting, Paris, 12-13 December